Karen Julissa Loaeza-Reyes

Mrs. Karen Julissa Loaeza-Reyes

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
María Eugenia Sanchez-LeonMaría Eugenia Sanchez-Leon
María Eugenia Sanchez-Leon
KLKaren Julissa Loaeza-Reyes
Karen Julissa Loaeza-Reyes
CMCarlos Alberto Matias-Cervantes
Carlos Alberto Matias-Cervantes
GAGabriel Mayoral Andrade
Gabriel Mayoral Andrade
Eduardo Perez-CamposEduardo Perez-Campos
Eduardo Perez-Campos
María del Socorro Pina-CansecoMaría del Socorro Pina-Canseco
María del Socorro Pina-Canseco
LOX-1, ORL-1, or lectin-like oxidized low-density lipoprotein receptor 1 is a transmembrane glycoprotein that binds and internalizes ox-LDL in foam cells. LOX-1 is the main receptor for oxidized low-density lipoproteins (ox-LDL). The LDL comes from food intake and circulates through the bloodstream. LOX-1 belongs to scavenger receptors (SR), which are associated with various cardiovascular diseases. The most important and severe of these is the formation of atherosclerotic plaques in the intimal layer of the endothelium. These plaques can evolve into complicated thrombi with the participation of fibroblasts, activated platelets, apoptotic muscle cells, and macrophages transformed into foam cells. This process causes changes in vascular endothelial homeostasis, leading to partial or total obstruction in the lumen of blood vessels. This obstruction can result in oxygen deprivation to the heart. Recently, LOX-1 has been involved in other pathologies, such as obesity and diabetes mellitus. However, the development of atherosclerosis has been the most relevant due to its relationship with cerebrovascular accidents and heart attacks. In this review, we will summarize findings related to the physiologic and pathophysiological processes of LOX-1 to support the detection, diagnosis, and prevention of those diseases.

13 April 2020
Verified
Book
Closed access
UCUniversidad Santiago de Cali
Universidad Santiago de Cali
OLOmaira Vera Lizcano
Omaira Vera Lizcano
CGCarla Sodré Grassini Gomes
Carla Sodré Grassini Gomes
UJUniversidad Federal de Rio de Janeiro
Universidad Federal de Rio de Janeiro
CACatalina Tovar Acero
Catalina Tovar Acero
UBUniversidad de Barcelona
Universidad de Barcelona
Realizar este libro de revisión con temas de investigación actual, sin mostrar resultados, sino antecedentes del proceso investigativo, nos ha permitido contar de forma extensa los fundamentos teóricos de donde se genera la nueva investigación básica y la fundamentación para la investigación clínica.

13 April 2020
Verified
Book Chapter
Closed access
UOUniversidad Autónoma Benito Juárez de Oaxaca
Universidad Autónoma Benito Juárez de Oaxaca
KLKaren Julissa Loaeza-Reyes
Karen Julissa Loaeza-Reyes
ARAdriana Moreno Rodriguez Adriana Moreno Rodríguez
Adriana Moreno Rodriguez Adriana Moreno Rodríguez
PCPedro Antonio Hernandez Cruz
Pedro Antonio Hernandez Cruz
UMUniversidad Nacional Autónoma de México
Universidad Nacional Autónoma de México
EZEdgar Zenteno
Edgar Zenteno
La enfermedad de Chagas es una antropozoonosis del continente americano que se ha extendido desde sus fronteras originales mediante la migración. Es causada por el protozoario Trypanosoma cruzi. La diferencia en cuanto a la severidad de la enfermedad, se ha atribuido al pleomorfismo natural que presenta T. cruzi.